Cargando…

Usefulness of autotaxin for the complications of liver cirrhosis

BACKGROUND: Autotaxin (ATX) has been reported as a direct biomarker for estimating the evaluation of liver fibrosis. But available data on ATX as a useful biomarker for the complications of liver cirrhosis (LC) are scant. AIM: To assess the clinical usefulness of ATX for assessing the complications...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Xue, Uojima, Haruki, Setsu, Toru, Okubo, Tomomi, Atsukawa, Masanori, Furuichi, Yoshihiro, Arase, Yoshitaka, Hidaka, Hisashi, Tanaka, Yoshiaki, Nakazawa, Takahide, Kako, Makoto, Kagawa, Tatehiro, Iwakiri, Katsuhiko, Terai, Shuji, Koizumi, Wasaburo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952300/ https://www.ncbi.nlm.nih.gov/pubmed/31933517 http://dx.doi.org/10.3748/wjg.v26.i1.97

Ejemplares similares

The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency
por: Shao, Xue, et al.
Publicado: (2022)

Relationship between response to lusutrombopag and splenic volume
por: Uojima, Haruki, et al.
Publicado: (2018)

A suspected case of Clostridium perfringens sepsis with intravascular hemolysis after transhepatic arterial chemoembolization: a case report
por: Uojima, Haruki, et al.
Publicado: (2019)

Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib
por: Azuma, Shintaro, et al.
Publicado: (2020)

Author Correction: Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib
por: Azuma, Shintaro, et al.
Publicado: (2021)

Rapid Regression of Advanced Hepatocellular Carcinoma Associated with Elevation of Des-Gamma-Carboxy Prothrombin after Short-Term Treatment with Sorafenib – A Report of Two Cases
por: Nakazawa, Takahide, et al.
Publicado: (2010)

Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis
por: Uojima, Haruki, et al.
Publicado: (2017)

Undifferentiated Embryonal Sarcoma of the Liver Identified after the Initial Diagnosis of a Hepatic Cyst
por: Manabe, Yusaku, et al.
Publicado: (2020)

Late-onset benefit in progressive advanced hepatocellular carcinoma with continued sorafenib therapy: a case report
por: Okuwaki, Yusuke, et al.
Publicado: (2012)

Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)–CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report
por: Jiang, Weimin, et al.
Publicado: (2014)

Cartilage-hair Hypoplasia Complicated with Liver Cirrhosis Due to Chronic Intrahepatic Cholestasis
por: Kogami, Taro, et al.
Publicado: (2021)

Reply:
por: Arase, Yoshitaka, et al.
Publicado: (2020)

Peliosis hepatis disseminated rapidly throughout the liver in a patient with prostate cancer: a case report
por: Hidaka, Hisashi, et al.
Publicado: (2015)

Reply:
por: Arase, Yoshitaka, et al.
Publicado: (2020)

Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
por: Fukushima, Taito, et al.
Publicado: (2023)

Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
por: Nakazawa, Takahide, et al.
Publicado: (2014)

Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma
por: Chuma, Makoto, et al.
Publicado: (2020)

The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma
por: Kawamura, Atsushi, et al.
Publicado: (2022)

Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study
por: Uojima, Haruki, et al.
Publicado: (2017)

Successful Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices Using Foam Sclerosant Followed by Glue Embolization of Gastrorenal Shunt via the Brachial Vein Approach in a Severely Obese Patient
por: Tsuruya, Kota, et al.
Publicado: (2019)

Safety and Efﬁcacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis
por: Ogushi, Katsuaki, et al.
Publicado: (2020)

Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma
por: Takada, Juichi, et al.
Publicado: (2015)

Hepatocellular carcinoma effective stereotactic body radiotherapy using Gold Anchor and the Synchrony system: Two case reports and review of literature
por: Masuda, Sakue, et al.
Publicado: (2022)

First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan
por: Tsuruya, Kota, et al.
Publicado: (2023)

Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment
por: Chuma, Makoto, et al.
Publicado: (2022)

Comparative study between sorafenib and lenvatinib as the first‐line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real‐world setting
por: Fukushima, Taito, et al.
Publicado: (2021)

Intraperitoneal bleeding after balloon-occluded retrograde transvenous obliteration: a case report
por: Furue, Yasuaki, et al.
Publicado: (2015)

Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus
por: Arai, Taeang, et al.
Publicado: (2022)

Splenectomy for Torsion of a Wandering Spleen in a Patient with Myeloproliferative Disease
por: Imawari, Kana, et al.
Publicado: (2021)

Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B
por: Nagata, Naruhiko, et al.
Publicado: (2016)

Complete Response after Short-Term Sorafenib Treatment in a Patient with Lymph Node Metastasis of Hepatocellular Carcinoma
por: Mizukami, Hajime, et al.
Publicado: (2012)

A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma
por: Kobayashi, Satoshi, et al.
Publicado: (2022)

Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy
por: Masuda, Sakue, et al.
Publicado: (2020)

Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatment
por: Shomura, Masako, et al.
Publicado: (2016)

The prevalence and natural history of hepatic cysts examined by ultrasound: a health checkup population retrospective cohort study
por: Tsuruya, Kota, et al.
Publicado: (2022)

Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial
por: Okubo, Tomomi, et al.
Publicado: (2021)

Another name for autotaxin
por: Dove, Alan W.
Publicado: (2002)

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
por: She, Sha, et al.
Publicado: (2022)

Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites
por: Arase, Yoshitaka, et al.
Publicado: (2018)

Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients
por: Hirose, Shunji, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vo5oifeqptuo0b1g0revd3gp6a